Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers

Psychopharmacology

Volumn 190, Issue 4, 2007, Pages 507-516

  Giménez, Sandra ^a,b   Clos, Susana ^a   Romero, Sergio ^a,c   Grasa, Eva ^a   Morte, Adelaida ^a   Barbanoj, Manuel J ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

Author keywords

Antipsychotics; Healthy volunteers; Polysomnography; Single morning oral intake; Spectral analysis; Subjective evaluations

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; RISPERIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; LABORATORY TEST; MALE; NIGHT SLEEP; NORMAL HUMAN; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SINGLE DRUG DOSE; SLEEP; SLEEP TIME; SLOW WAVE SLEEP;

ADMINISTRATION, ORAL; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELECTROENCEPHALOGRAPHY; FEMALE; HALOPERIDOL; HUMANS; MALE; POLYSOMNOGRAPHY; REFERENCE VALUES; RISPERIDONE; SLEEP; SLEEP, REM; TIME FACTORS; WAKEFULNESS;

EID: 33846817166     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0633-7     Document Type: Article

References (32)

1. Aeschbach D, Borbély AA (1993) All night dynamics of the human sleep EEG. J Sleep Res 2:70-81
2. Åkerstedt T, Hume K, Minors D, Waterhouse J (1994a) The meaning of good sleep: a longitudinal study of polysomnography and subjective sleep quality. J Sleep Res 3:152-158
3. Åkerstedt T, Hume K, Minors D, Waterhouse J (1994b) The subjective meaning of good sleep - an intraindividual approach using the Karolinska Sleep Diary. Percept Mot Skills 79:287-296
4. Åkerstedt T, Hume K, Minors D, Waterhouse J (1997) Good sleep - its timing and physiological characteristics. J Sleep Res 6:221-229
5. Barbanoj MJ, Grasa E, Morte A, Romero S, Clos S, Giménez S, Benito Ll, Yritia M, Pérez V, Anderer P (2004) Topographic EEG changes after single oral doses of atypical neuroleptics with different pharmacological profile in healthy young subjects (abstract). 13th meeting of the IPEG (International Pharmaco-EEG Society), Amberes, Belgium (8-12 September)
6. Borbély AA, Mattmann P, Loepfe M, Strauch I, Lehmann D (1983) Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum Neurobiol 4:189-194
7. Bobérly AA, Trachsel L, Tobler I (1988) Effect of ritanserin on sleep stages and sleep EEG in the rat. Eur J Pharmacol 156:275-278
8. Dijk DJ, Beersma DGM, Daan S, Van den Hoofdakker RH (1989) Effects of seganserin, a 5HT2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol 171:207-218
9. Dugovic C, Wauquier A, Janssen PAJ (1989) Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat. Neuropharmacology 28:1431-1433
10. Feinberg I, Floyd TC (1979) Systematic trends across the night in human sleep cycles. Psychophysiology 16:282-291
11. Itil TM, Gannon P, Hsu W, Klingenberg H (1970) Digital computer analyzed sleep and resting EEG during haloperidol treatment. Am J Psychiatry 127:462-471
12. Janssen P, Niemeggeers CJ, Awouters F, Schellekens KH, Megens AA, Meert TF (1988) Pharmacology of risperidone (R64766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther 244:685-693
13. Lee DY, Lee KU, Kwon JS, Jang IJ, Cho MJ, Shin SG, Woo JI (1999) Pharmacokinetic-pharmacodynamic modeling of risperidone effects on electroencephalography in healthy volunteers. Psychopharmacology 144:272-278
14. Lindberg N, Virkkunen M, Tani P, Appelberg B, Virkkala J, Rimón R, Porkka-Heiskanen T (2002) Effect of a single-dose of olanzapine on sleep in healthy females and males. Int Clin Psychopharmacol 17:177-184
15. Maixner S, Tandon R, Eiser A, Taylor S, DeQuardo JR, Shipley J (1998) Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: a replication and extension. Am J Psychiatry 155:1600-1602
16. Miyamoto S, Duncan GE, Goff DC, Lieberman JA (2002) Therapeutics of schizophrenia. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) American College of Neuropsychopharmacology: the fifth generation of progress. Lippincott, Williams and Wilkins, Philadelphia, PA, pp 775-807
17. Nicholson AN, Pascoe PA (1991) Presynaptic alpha 2-adrenoceptor function and sleep in man: studies with clonidine and idazoxan. Neuropharmacology 30:367-372
18. Pace-Schott EF, Hobson JA (2002) Basic mechanisms of sleep: new evidence on the neuroanatomy and neuromodulation of the NREM-REM cycle. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) American College of Neuropsychopharmacology: the fifth generation of progress. Lippincott, Williams and Wilkins, Philadelphia, PA, pp 1859-1877
19. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. U.S. Government Printing Office, Washington, DC
20. Saletu B, Wessely P, Grünberger J, Schultes M (1987a). Erste klinische Erfahrungen mit einem neuen schlafanstossenden Benzodiacepin Cinolazepam mittels eines Selbstbeurteilungsbogens für Schalf - und Aufwachqualität (SSA). Neuropsychiatrie 1:169-176
21. Saletu B, Anderer P, Kinsperger K, Grünberger J (1987b). Topographic brain mapping of EEG in neuropsychopharmacology - Part II. Clinical applications (pharmaco-EEG imaging). Methods Find Exp Clin Pharmacol 9:385-408
22. Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, Rosas-Laurrabaquio M (1999) Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry 46:141-143
23. Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, Rosas M, Brunner E (2004) Low delta sleep predicted a good clinical response to olanzapine administration in schizophrenic patients. Rev Invest Clin 56:345-350
24. Schlösser R, Röschker J, Rossbach W, Benkert O (1998) Conventional and spectral power analysis of all-night sleep EEG after subchronic treatment with paroxetine in healthy male volunteers. Eur Neuropsychopharmacol 8:273-278
25. Sharpley AL, Elliott JM, Attenburrow MJ, Cowen PJ (1994) Slow wave sleep in humans: Role of 5-HTA and 5HT2C receptors. Neuropharmacology 33:467-471
26. Sharpley AL, Vassallo CM, Cowen PJ (2000) Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT2c receptors in vivo. Biol Psychiatry 47:468-470
27. Sharpley AL, Bhagwagar Z, Hafizi S, Whale WR, Gijsman HJ, Cowen PJ (2003) Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients. J Clin Psychiatry 64:192-196
28. Stephan FT, Tandon R, Shipley JE, Eiser AS (1991) Effect of neuroleptic treatment on polysomnographic measures in schizophrenia. Biol Psychiatry 30:904-912
29. Tandon R (1998) Antipsychotic agents. In: Klein DF, Rowland LP (eds) Current psychotherapeutic drugs. Brunner/Mazel Publishers, New York, pp 120-154
30. Viola AU, Brandenberger G, Toussaint M, Bouhours P, Macher JP, Luthringer R (2002) Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers. Clin Neurophysiol 113:429-434
31. Warrington SJ (1997) Ethical aspects of research in healthy volunteers. In: O'Grady J, Joubert PH (eds) Handbook of phase I/II clinical drug trials. CRS Press, Boca Raton, pp 103-110
32. Worrel JA, Marken PA, Beckman SE, Ruether VL (2000) Atypical antipsychotic agents: a critical review. Am J Health - Syst Pharm 57:238-255